InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in InflaRx N.V. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −5 vs. Q4 2021
- Shares held
- 6.45M
- −2.83M (−30.5%) vs. Q4 2021
- Total value
- $12.0M
- −$32.1M (−72.8%) vs. Q4 2021
- New holders
- 4
- 8 more added
- Sold out
- 9
- 9 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FinTrust Capital Advisors, LLC | 100 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 538 | $1.00K | 0.00% | −454−45.8% | Reduced |
| BlackRock Inc. | 2,047 | $4.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,481 | $5.00K | 0.00% | −2,011−44.8% | Reduced |
| Steward Partners Investment Advisory, LLC | 4,800 | $9.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 6,805 | $13.0K | 0.00% | +6,805 | New |
| ETF Managers Group, LLC | 13,403 | $32.0K | 0.00% | +49+0.4% | Added |
| D. E. Shaw & Co., Inc. | 23,161 | $42.0K | 0.00% | −3,892−14.4% | Reduced |
| IPG Investment Advisors LLC | 25,900 | $47.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 26,327 | $48.0K | 0.00% | +7,336+38.6% | Added |
| Pacifica Partners Inc. | 20,585 | $48.0K | 0.03% | 00.0% | Unchanged |
| Virtu Financial LLC | 28,909 | $53.0K | 0.00% | +28,909 | New |
| Citadel Advisors LLC | 29,363 | $54.0K | 0.00% | −26,711−47.6% | Reduced |
| Marquette Asset Management, LLC | 33,215 | $61.0K | 0.01% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 33,229 | $61.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 34,353 | $63.0K | 0.00% | +34,353 | New |
| Raymond James & Associates | 37,204 | $68.0K | 0.00% | −28,338−43.2% | Reduced |
| Two Sigma Investments, LP | 49,226 | $90.0K | 0.00% | −10,943−18.2% | Reduced |
| Birchview Capital, LP | 70,000 | $128.0K | 0.09% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 73,860 | $135.0K | 0.02% | −251,140−77.3% | Reduced |
| Franklin Street Advisors Inc | 75,100 | $137.0K | 0.01% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 100,000 | $183.0K | 0.17% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 100,100 | $183.0K | 0.00% | +90,000+891.1% | Added |
| Raymond James Financial Services Advisors, Inc. | 148,584 | $272.0K | 0.00% | +52,910+55.3% | Added |
| Millennium Management LLC | 175,005 | $320.0K | 0.00% | +161,141+1,162.3% | Added |
| Invesco Ltd. | 226,610 | $415.0K | 0.00% | +67,214+42.2% | Added |
| Renaissance Technologies LLC | 233,300 | $427.0K | 0.00% | +132,900+132.4% | Added |
| Laurion Capital Management LP | 242,429 | $444.0K | 0.01% | −257,571−51.5% | Reduced |
| Bank of Montreal | 241,000 | $603.0K | 0.00% | +241,000 | New |
| Ikarian Capital, LLC | 349,468 | $639.0K | 0.19% | +18,420+5.6% | Added |
| Morgan Stanley | 756,032 | $1.38M | 0.00% | −117,629−13.5% | Reduced |
| Suvretta Capital Management, LLC | 3,285,000 | $6.01M | 0.18% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −1,161,736−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −875,297−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −530,432−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −197,607−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −100,706−100.0% | Sold out |
| Kingsview Wealth Management, LLC | 0 | $0 | 0.00% | −71,870−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −27,414−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| Harbour Investments, Inc. | – | – | – | – | Not filed |